March 2, 2017
Arix Bioscience, Takeda developing group business
Arix Bioscience and Takeda will work together to combine complementary skills and experience across important therapeutic areas in a strategic deal.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Asia
March 2, 2017
90% of the cases analysed are carriers of at least one genetic mutation
Conceiving and bearing a child is a blessing in a couple’s life. While they are lost in rejoicing the good news, they often ignore the fact that they can be passing some serious genetic disorders to their child. Along with the features and traits, a child also inherits genetic disorders which their parents are the carrier.
February 28, 2017
Novo Nordisk submits NDA for its diabetes drug in Japan
Novo Nordisk has submitted a New Drug Application (NDA) to the Japanese Ministry of Health, Labour and Welfare for semaglutide, a new glucagon-like peptide-1 (GLP-1) analogue administrated once-weekly, for the treatment of adults with type 2 diabetes.
February 27, 2017
Premaitha Health buys Taiwanese Yourgene Bioscience
Premaitha Health, an international molecular diagnostics group focused on prenatal testing, has acquired Taiwanese Yourgene Bioscience.
February 27, 2017
Global Market Insights says clinical trial management system market worth $2 billion by 2024
Growing prevalence of chronic diseases, surge in clinical trials outsourcing, rising R&D cost and favorable government initiatives will drive global clinical trial management system market size, according to a report by Global Market Insights.
February 24, 2017
What belongs in medical kits for climbers and hikers?
For mountain climbers and hikers, injuries often include broken bones, sprains and skin wounds, but many don’t carry the right supplies for the injuries and illnesses they are most likely to face, a recent study found.
February 24, 2017
Oncology focused drugmaker Xynomic Pharmaceuticals secures Abexinostat global rights
Oncology drug research and development company Xynomic Pharmaceuticals has acquired exclusive worldwide rights to develop a novel HDAC inhibitor targeting hematological and solid tumors, Abexinostat.
February 23, 2017
China updates key drug list in boost for Big Pharma
China has updated list of medicines covered by basic medical insurance schemes, a long-awaited fillip for drugmakers in the world’s second-largest drug market where many new drugs have been kept out of patients’ reach because of high costs.
February 21, 2017
Neovacs’s lupus and dermatomyositis vaccine to sell in China
Neovacs has signed with BioSense Global a commercial license option agreement for its IFNalpha Kinoid vaccine to treat lupus and dermatomyositis in China, worth up to €65 million in upfront and milestone payments, not including double-digit sales royalties.
February 20, 2017
Russian Government drive to increase domestic manufacturing fuelling growth at CPhI Russia
The partnerships and deals struck at CPhI Russia have helped establish Russia at the forefront of pharmerging markets and it is expected to reach a value of $31.2 billion by 2019.